✦ LIBER ✦

Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation

✍ Scribed by Fletcher, Courtney V; Chinnock, Barbara J; Chace, Beverly; Balfour, Henry H

Book ID: 109844343
Publisher: Nature Publishing Group
Year: 1988
Tongue: English
Weight: 601 KB
Volume: 44
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.1988.131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of high-dose oral acyclovir with

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

✍ Thomas C. Bailey; Neil A. Ettinger; Gregory A. Storch; Elbert P. Trulock; Dougla 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 104 KB

Quantity of cytomegalovirus viruria is a

Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation

✍ Cope, A. V.; Sweny, P.; Sabin, C.; Rees, L.; Griffiths, P. D.; Emery, V. C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Studies have shown that risk factors for human cytomegalovirus (HCMV) disease after renal transplant include primary infection (virus of donor origin infecting a non-immune individual), re-infection (virus of donor origin infecting a immune individual), and the detection of viraemia (as a marker of

High-dose acyclovir and intravenous immu

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

✍ Eytan Mor; Burt R. Meyers; Ozgur Yagmur; Keiji Kishikawa; Patricia A. Sheiner; S 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 473 KB

High-dose acyclovir and pre-emptive ganc

High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation

✍ Hazar, V; Kansoy, S; Küpesiz, A; Aksoylar, S; Kantar, M; Yeşilipek, A 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Oral versus intravenous ganciclovir for

Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation

✍ J. Szer; S. Durrant; A. P. Schwarer; K. F. Bradstock; J. Gibson; C. Arthur; L. B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Administration and pharmacokinetics of h

Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease

✍ Perry, J J; Fleming, R A; Rocco, M V; Petros, W P; Bleyer, A J; Jr, JE Radford; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB